Your browser doesn't support javascript.
loading
Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes.
Bax, Heather J; Chauhan, Jitesh; Stavraka, Chara; Santaolalla, Aida; Osborn, Gabriel; Khiabany, Atousa; Grandits, Melanie; López-Abente, Jacobo; Palhares, Lais C G F; Chan Wah Hak, Charleen; Robinson, Alexandra; Pope, Amy; Woodman, Natalie; Naceur-Lombardelli, Cristina; Malas, Sadek; Coumbe, Jack E M; Nakamura, Mano; Laddach, Roman; Mele, Silvia; Crescioli, Silvia; Black, Anna M; Lombardi, Sara; Canevari, Silvana; Figini, Mariangela; Sayasneh, Ahmad; Tsoka, Sophia; FitzGerald, Kevin; Gillett, Cheryl; Pinder, Sarah; Van Hemelrijck, Mieke; Kristeleit, Rebecca; Ghosh, Sharmistha; Montes, Ana; Spicer, James; Karagiannis, Sophia N; Josephs, Debra H.
Afiliação
  • Bax HJ; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK.
  • Chauhan J; School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Hospital, London, UK.
  • Stavraka C; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK.
  • Santaolalla A; School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Hospital, London, UK.
  • Osborn G; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK.
  • Khiabany A; School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Hospital, London, UK.
  • Grandits M; Cancer Centre at Guy's, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • López-Abente J; Translational Oncology & Urology Research (TOUR), School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Hospital, London, UK.
  • Palhares LCGF; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK.
  • Chan Wah Hak C; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK.
  • Robinson A; School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Hospital, London, UK.
  • Pope A; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK.
  • Woodman N; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK.
  • Naceur-Lombardelli C; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK.
  • Malas S; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK.
  • Coumbe JEM; Cancer Centre at Guy's, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Nakamura M; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK.
  • Laddach R; King's Health Partners Cancer Biobank, School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Hospital, London, UK.
  • Mele S; King's Health Partners Cancer Biobank, School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Hospital, London, UK.
  • Crescioli S; King's Health Partners Cancer Biobank, School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Hospital, London, UK.
  • Black AM; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK.
  • Lombardi S; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK.
  • Canevari S; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK.
  • Figini M; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK.
  • Sayasneh A; Department of Informatics, Faculty of Natural, Mathematical & Engineering Sciences, King's College London, Bush House, London, UK.
  • Tsoka S; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK.
  • FitzGerald K; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK.
  • Gillett C; Guy's and St Thomas' Oncology & Haematology Clinical Trials (OHCT), Guy's Cancer Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Pinder S; Guy's and St Thomas' Oncology & Haematology Clinical Trials (OHCT), Guy's Cancer Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Van Hemelrijck M; Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Milan, Italy.
  • Kristeleit R; Biomarker Unit, Dipartimento di Ricerca Applicata e Sviluppo Tecnologico (DRAST), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Ghosh S; Cancer Centre at Guy's, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Montes A; Department of Informatics, Faculty of Natural, Mathematical & Engineering Sciences, King's College London, Bush House, London, UK.
  • Spicer J; Epsilogen Ltd., Waterfront, ARC West London, Manbre Road, Hammersmith, London, UK.
  • Karagiannis SN; King's Health Partners Cancer Biobank, School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Hospital, London, UK.
  • Josephs DH; King's Health Partners Cancer Biobank, School of Cancer & Pharmaceutical Sciences, King's College London, Guy's Hospital, London, UK.
Br J Cancer ; 128(2): 342-353, 2023 01.
Article em En | MEDLINE | ID: mdl-36402875

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido